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Division of labor among oxidoreductases: 
TMX1 preferentially acts on transmembrane 
polypeptides
ABSTRACT The endoplasmic reticulum (ER) is the site of maturation for secretory and mem-
brane proteins in eukaryotic cells. The lumen of the mammalian ER contains >20 members of 
the protein disulfide isomerase (PDI) superfamily, which ensure formation of the correct set of 
intramolecular and intermolecular disulfide bonds as crucial, rate-limiting reactions of the pro-
tein folding process. Components of the PDI superfamily may also facilitate dislocation of 
misfolded polypeptides across the ER membrane for ER-associated degradation (ERAD). The 
reasons for the high redundancy of PDI family members and the substrate features required 
for preferential engagement of one or the other are poorly understood. Here we show that 
TMX1, one of the few transmembrane members of the family, forms functional complexes 
with the ER lectin calnexin and preferentially intervenes during maturation of cysteine-contain-
ing, membrane-associated proteins while ignoring the same cysteine-containing ectodomains 
if not anchored at the ER membrane. As such, TMX1 is the first example of a topology-specif-
ic client protein redox catalyst in living cells.
INTRODUCTION
The mammalian endoplasmic reticulum (ER) contains 23 members 
of the protein disulfide isomerase (PDI) family (Tannous et al., 2015). 
These are characterized by the presence of one or more thioredoxin 
(Trx)-like domains, which may contain an active site with a Cys-Xxx-
Xxx-Cys (CXXC) consensus sequence. Enzymatically active PDIs 
catalyze formation, reduction, and isomerization of intramolecular 
or intermolecular covalent bonds between luminal cysteine residues 
of newly synthesized polypeptides entering the secretory pathway, 
conferring structural stability on the native proteome (Ellgaard 
and Ruddock, 2005; Appenzeller-Herzog and Ellgaard, 2008; 
Bulleid, 2012; Oka and Bulleid, 2013). The reason for the high num-
ber of PDIs in the ER and their individual roles in protein biogenesis 
is unclear (Bulleid, 2012). Individual members of the PDI family show 
some substrate preference. For example, ERp57 forms functional 
complexes with calnexin (CNX) and calreticulin (CRT; Oliver et al., 
1997; Zapun et al., 1998; Frickel et al., 2002; Pollock et al., 2004; 
Jessop et al., 2007). CNX and CRT are ER lectins that bind newly 
synthesized polypeptides displaying monoglucosylated, N-linked 
oligosaccharides (Hammond et al., 1994; Hebert et al., 1995). 
ERp57 acts on their ligands, that is, viral glycoproteins (Molinari and 
Helenius, 1999; Solda et al., 2006) or endogenous glycoproteins 
sharing common structural domains (Jessop et al., 2007), thereby 
promoting the formation of native disulfide bonds. In contrast, P5 
targets BiP-bound proteins (Jessop et al., 2009), and PDI, ERp72, 
and ERdj5 facilitate dislocation of misfolded proteins or toxin sub-
units from the ER lumen into the cytosol (Majoul et al., 1997; Tsai 
et al., 2001; Molinari et al., 2002; Forster et al., 2006).
The majority of the PDIs are soluble luminal proteins character-
ized by a KDEL-like retention signal and transcriptional up-regula-
tion in response to activation of the unfolded protein response 
(Tasanen et al., 1992; Roy and Lee, 1999; Anelli et al., 2002; 
Cunnea et al., 2003; Lee et al., 2003; Chichiarelli et al., 2007; 
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(Table 1). To determine whether the selective immunoisolation of 
membrane proteins was symptomatic of the intrinsic specificity of 
TMX1 for membrane-bound substrates, we used a series of model 
polypeptides characterized by the presence of a cysteine-contain-
ing ectodomain tethered or nontethered at the ER membrane 
(Figure 2A).
First, MEFs were mock transfected (EV [empty vector], Figure 2B, 
lane 1) or transfected with a plasmid for expression of β1-tagged 
TMX1C/A (lane 2) or with plasmids for expression of TMX1C/A and 
the folding-competent, membrane-bound BACE501 (lane 3), the 
folding-competent and soluble BACE501Δ (lane 4; Solda et al., 
2007), the folding-defective, membrane-bound BACE457 (lane 5), 
or the folding-defective, soluble BACE457Δ (lane 6; Molinari et al., 
2002). Cells were detergent solubilized, and the ectopically ex-
pressed, hemagglutinin (HA)-tagged BACE variants were immuno-
isolated from postnuclear supernatants. The immunocomplexes 
were separated in SDS–PAGE and transferred to polyvinylidene flu-
oride (PVDF) membranes. The presence of the BACE variants was 
revealed by Western blot (WB) with anti-HA antibodies (Figure 2B, 
top). The association of TMX1C/A was assessed in the same PVDF 
membrane upon decoration of the membrane with anti-TMX1 anti-
bodies (Figure 2B, bottom).
The membrane-bound BACE501 is separated into two forms 
(G is the Golgi, mature, endoglycosidase H [EndoH]–resistant 
form, and E is the ER, immature, EndoH-sensitive form of the pro-
tein; Figure 2B, lane 3; Solda et al., 2007). In the cell lysate, the 
soluble BACE501Δ is only present in the E form, as the G form is 
rapidly released in the extracellular medium (Solda et al., 2007). 
BACE457 and BACE457Δ are only present in their E form, since 
they are ER-retained, folding-defective polypeptides (Molinari 
et al., 2002). The experiment reveals that TMX1C/A associates 
with the membrane-bound versions of BACE (i.e., BACE501 and 
BACE457; Figure 2B, bottom, lanes 3 and 5). In contrast, TMX1C/A 
is not found in immunocomplexes containing the soluble variants 
of BACE (i.e., BACE501Δ and BACE457Δ; Figure 2B, bottom, 
lanes 4 and 6, respectively). The selectivity of TMX1 for 
Galligan and Petersen, 2012). Five members of the family, TMX1–
5, are anchored at the ER membrane. Although no information is 
available for TMX5, for TMX1–4 it has been reported that they are 
not induced by cellular stresses (Haugstetter et al., 2005; Matsuo 
et al., 2009; Kozlov et al., 2010b; Sugiura et al., 2010; Koritzinsky 
et al., 2013).
Here we focus on TMX1, which is highly expressed in kidney, 
liver, placenta, and lungs (Matsuo et al., 2001). The presence of a 
proline residue at position 2 of the TMX1 catalytic site (CPAC, 
residues 56–59) hints at a possible role of TMX1 as an ER reduc-
tase (Hatahet and Ruddock, 2009). Consistent with such a role, 
TMX1 facilitates cell intoxication by ricin and abrin, which requires 
a reductive step promoting dislocation of the catalytic subunit to 
the cell cytosol (Pasetto et al., 2012) and reduces insulin disulfides 
in vitro (Matsuo et al., 2001). Deletion of the TMX1 gene results in 
susceptibility to liver damage in mice (Matsuo et al., 2013). At the 
cellular level, TMX1 deletion has no phenotype, indicating the 
activation of compensatory mechanisms (unpublished results; 
Matsuo et al., 2013). In this study, we report on a mass spectrom-
etry analysis with a trapping mutant version of TMX1 expressed in 
mammalian cultured cells that reveals the selective association of 
TMX1 with a series of endogenous membrane-bound client pro-
teins. Systematic analysis with membrane-bound and soluble 
model polypeptides confirmed the exquisite preference of TMX1 
for membrane-bound substrates and identified TMX1 as the first 
example of topology-specific PDI transiently associating with 
both folding-competent and folding-defective membrane-bound 
polypeptides.
RESULTS
TMX1 preferentially associates with 
membrane-bound substrates
During the reaction cycles leading to disulfide bond formation, dis-
assembly, or rearrangement, active-site cysteines of PDIs transiently 
form short-lived mixed disulfides with surface-exposed cysteine 
residues of proteins expressed in the ER lumen (Huppa and Ploegh, 
1998; Molinari and Helenius, 1999). The re-
placement of the resolving carboxy-terminal 
cysteine residue in the PDI catalytic site 
efficiently traps mixed disulfides in the re-
ductive pathway (Figure 1A; Hatahet and 
Ruddock, 2009). Thus PDI trapping mutants 
have been used to identify endogenous 
substrates of select ER-resident oxidoreduc-
tases such as ERp57, PDI, P5, ERp18, ERp72, 
ERp46, and ERdj5 (Dick and Cresswell, 
2002; Jessop et al., 2007, 2009; Schulman 
et al., 2010; Oka et al., 2013).
To identify endogenous substrates of 
TMX1, we expressed the trapping mutant 
TMX1C/A (Figure 1B) in mouse embryonic 
fibroblasts (MEFs) and performed a mass 
spectrometry analysis of the cellular pro-
teins coimmunoisolated with the ectopically 
expressed reductase. In contrast to the anal-
yses performed for other PDIs, which re-
vealed both soluble and membrane-bound 
proteins as endogenous substrates (Dick 
and Cresswell, 2002; Jessop et al., 2007, 
2009; Schulman et al., 2010; Oka et al., 
2013), TMX1C/A selectively trapped a series 
of cysteine-containing membrane proteins 
FIGURE 1: TMX1 trapping mutant to stabilize TMX1–substrate complexes. (A) Mechanism of 
reduction of disulfide bonds catalyzed by members of the PDI family. The formation of a mixed 
disulfide by the nucleophilic attack of the N-terminal active-site cysteine on a substrate disulfide 
bond. The resulting mixed disulfide can be resolved upon nucleophilic attack of the enzyme 
C-terminal active-site cysteine on the mixed disulfide. (B) TMX1 and TMX1C/A constructs. The 
replacement of the resolving cysteine (amino acid 59 of the TMX1 sequence) with an alanine 
residue substantially stabilizes mixed disulfides between TMX1 and its substrates. SS, signal 
sequence; Trx, thioredoxin-like domain; TM, transmembrane domain. The sequence of the active 
site of TMX1 and TMX1C/A and the position of the active site residues are shown.
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of their oligosaccharides (Supplemental Figure S1A; Solda et al., 
2007). BACE (Figure 3, A and B) or TMX1 variants (Figure 3, C and 
D) were immunoisolated from detergent extracts, and complexes 
were analyzed in nonreducing (Figure 3, A and C) and reducing 
SDS–PAGE (Figure 3, B and D).
In nonreducing gels, BACE501 and BACE501Δ expressed alone 
(Figure 3A, lanes 2 and 3) or in combination with TMX1 (lanes 6–9) 
are separated in a series of radiolabeled bands corresponding to 
various oxidation forms (Figure 3A and Supplemental Figure S1B, 
fully oxidized [fOx] and partially oxidized [pOx] for BACE501 and 
BACE501Δ, respectively). The bands with faster electrophoretic mo-
bility correspond to BACE forms with lower hydrodynamic radius 
due to the presence of intramolecular disulfide bonds (fOx in Figure 
3A and Supplemental Figure S1B) that relapse into the reduced 
(Red) BACE501 or BACE501Δ forms in the reducing gel (Figure 3, B 
and D, and Supplemental Figure S1B; Braakman et al., 1992).
In cells in which the membrane-bound BACE501 was cotrans-
fected with the trapping mutant TMX1C/A, separation of the BACE 
immunoisolates under nonreducing conditions revealed an abun-
dant labeled polypeptide band with an apparent molecular weight 
(MW) of ∼90 kDa (MD; Figure 3A, lane 7). Sample reduction dissoci-
ated the radiolabeled 90-kDa polypeptide into its components: 
BACE501, with an apparent MW of ∼60 kDa, and a radiolabeled 
polypeptide, with an apparent MW of ∼35 kDa (Figure 3B, lane 7). 
Both the 90-kDa polypeptide (Figure 3A, lane 7) and the 35-kDa 
polypeptide (TMX1; Figure 3B, lane 7) are much less abundant 
when BACE501 is cotransfected with the wild-type form of TMX1, 
which is unable to stabilize the mixed disulfide with the substrate. 
This led us to conclude that the 90-kDa polypeptide is a mixed di-
sulfide (MD; Figure 3A, lane 7) containing BACE501 and TMX1C/A, 
which is dissociated under reducing conditions, releasing the radio-
labeled TMX1 polypeptide of 35 kDa (Figure 3B, lane 7). Consistent 
with this hypothesis, mixed disulfides were significantly more abun-
dant when the BACE501 was coexpressed with the trapping mutant 
than with the wild-type version of TMX1 (Figure 3C, lane 7 vs. 
lane 6). Moreover, both the MDs in the nonreducing gel (Figure 3A, 
lane 9) and the 35-kDa polypeptide in the reducing gel were virtu-
ally absent when the trapping mutant of TMX1 was cotransfected 
with the soluble BACE501Δ (Figure 3B, lane 9), which does not as-
sociate with TMX1 (Figure 2, B and C). Again, MDs were separated 
into their BACE501 and TMX1 constituents in the reducing gel 
(Figure 3D, lane 7). This confirms that the TMX1 trapping mutant 
stabilizes the otherwise short-lived MD intermediate of the 
BACE501 redox reaction. Cells expressing TMX1C/A and BACE501 
membrane-bound polypeptides was confirmed upon immunoiso-
lation from the cell lysates of the ectopically expressed, β1-
tagged TMX1C/A (Figure 2C, bottom), which shows the abundant 
coprecipitation of BACE501 and BACE457 (top, lanes 3 and 5). 
Confirming the specificity of this assay of the G and the E forms 
of BACE501, only the latter, which is in the ER, is in the TMX1C/A-
containing immunocomplexes (Figure 2C, lane 3). The associa-
tion with both BACE501 and BACE457 shows that TMX1 does 
not discriminate between folding-competent and folding-defec-
tive polypeptides.
To further confirm the preference of TMX1 for association with 
membrane-bound proteins, we assessed association of the TMX1 
trapping mutant with the soluble protein A1AT (Figure 2A; Perlmut-
ter, 2011) and of two variants of A1AT that were artificially tethered 
at the ER membrane with two different membrane anchors (Figure 
2A, A1AT-BACE and A1AT-CD3δ). Consistent with a preferential as-
sociation of TMX1 with membrane-bound polypeptides, TMX1C/A 
associated with A1AT only when tethered at the membrane (Figure 
2, D and E, lane 1 vs. lane 2). Of interest, and in contrast with the 
case of BACE proteins, the A1AT ectodomain contains a single cys-
teine residue. Hence, there are no intramolecular disulfides to be 
attacked by TMX1. However, there is evidence that the A1AT cys-
teine undergoes various reversible modifications, such as S-nitro-
sylation, S-glutathionylation, sulfenic acid formation, S-cysteinyl-
ation, and oxidation, which induce polymerization on the A1AT 
cysteine (Glaser et al., 1982; Tyagi and Simon, 1992; Miyamoto 
et al., 2000; Griffiths et al., 2002; Alam et al., 2011; Grek et al., 
2012). Each of these modifications could be attacked by the sub-
strate trap mutant of TMX1 to form a mixed disulfide.
TMX1 establishes mixed disulfides with newly synthesized 
membrane-bound BACE501
An active involvement of TMX1 in determining the fate of the asso-
ciating proteins should involve formation of mixed disulfides as re-
action intermediates (Figure 1A). To assess this directly, we per-
formed a pulse-and-chase experiment. MEFs were transfected with 
two empty vectors (Figure 3, A–D, EV, lane 1), with expression vec-
tors for BACE501, BACE501Δ, TMX1, or TMX1C/A and an empty 
vector (lanes 2–5), or with expression vectors for BACE501 and 
TMX1 (lane 6), BACE501 and TMX1C/A (lane 7), BACE501Δ and 
TMX1 (lane 8), or BACE501Δ and TMX1C/A (lane 9). Transfected cells 
were pulsed with [35S]methionine/cysteine for 13 min and chased for 
10 min. At this time of chase, the newly synthesized BACE501 vari-
ants are still folding in the ER, as confirmed by the EndoH sensitivity 
Gene 
name Protein name
Entry 
number
Luminal 
cysteines
Predicted 
glycans Protein topology
Itgb1 Integrin β-1 P09055 56 14 Single-pass type I
Slc3a2 4F2 cell-surface antigen heavy chain P10852 2 10 Single-pass type II
Ece1 Endothelin-converting enzyme 1 Q4PZA2 12 13 Single-pass type II
Lrrc59 Leucine-rich repeat–containing protein 59 Q922Q8 2 0 Single-pass type II
Ncstn Nicastrin P57716 11 17 Single-pass type I
Atp6ap1 V-type proton ATPase subunit S1 Q9R1Q9 2 8 Single-pass type I
Tspan3 Tetraspanin-3 Q9QY33 6 4 Multipass
Lrp10 Low-density lipoprotein receptor–related protein 10 Q7TQH7 30 4 Single-pass type I
Pld4 Phospholipase D4 Q8BG07 5 Several Single-pass type II
TABLE 1: Endogenous substrates of TMX1 identified by mass spectrometry analysis.
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are not overexpressing BACE501 (lanes 5 
and 9) led us to propose that CNX is a com-
ponent of TMX1 functional complexes, 
which are assembled or stabilized in the 
presence of TMX1 substrates.
BACE501:TMX1:CNX complexes
To assess whether CNX forms functional 
complexes with TMX1, we examined the 
consequences of cell exposure to castano-
spermine (CST), a glucose analogue that 
prevents association of newly synthesized 
proteins with CNX (Hammond et al., 1994). 
MEFs were mock transfected (EV; Figure 4, 
A and B, lanes 1 and 2), cotransfected with 
EV and a plasmid for expression of TMX1C/A 
(lanes 3 and 4), or cotransfected with EV and 
a plasmid for expression of BACE501 (lanes 
5 and 6) or with plasmids for expression of 
TMX1C/A and BACE501 (lanes 7 and 8). Be-
fore solubilization and immunoisolation of 
ectopic BACE501 (Figure 4A) or of endog-
enous CNX with the associated polypep-
tides (Figure 4B), cells were incubated for 
10 h in the absence (–) or presence (+) of 
CST to clear the CNX chaperone system of 
endogenous substrates (Figure 4, A and B, 
lanes 2 and 4) or of endogenous substrates 
and ectopically expressed BACE501 (lanes 
6 and 8). In the absence of CST, CNX 
strongly interacted with TMX1C/A, which is a 
nonglycosylated protein (Figure 4B, bot-
tom, lanes 3 and 7). This association was 
substantially reduced upon CST treatment 
(bottom, lanes 4 and 8; TMX1 is not glyco-
sylated, thus excluding the possibility of its 
direct, glycan-lectin association with CNX). 
Thus inhibition of endogenous (Figure 4B, 
lane 4) and endogenous plus ectopic (lane 
8) substrates access to the CNX chaperone 
system substantially reduces the fraction of 
TMX1 coprecipitated (i.e., participating in a 
functional complex) with CNX. Taken to-
gether, the data in Figures 3 and 4 show that 
CNX and TMX1 may form a functional com-
plex, which is stabilized by client substrates. 
This conclusion is supported by the ham-
pered association of TMX1 with CNX in cells 
with reduced protein synthesis (Figures 4, C, 
lane 4, and D, lane 3), or with defective N-
glycosylation upon exposure to tunicamycin 
(Figure 4, C, lane 5, and D, lane 4).
Characterization of TMX1C/A:BACE501 mixed disulfides 
by WB
To further confirm the selective involvement of TMX1 in mixed disul-
fides with membrane-bound clients, we expressed BACE501 alone 
(Figure 5A, lanes 1 and 2), with TMX1 (lanes 3 and 4), or with 
TMX1C/A (lanes 5 and 6). After immunoisolation of the HA-tagged 
bait, the immunocomplexes were separated in SDS–PAGE under 
nonreducing (NR; Figure 5A, lanes 1, 4, and 5) and reducing condi-
tions (R; lanes 2, 3, and 6). We then transferred proteins to a PVDF 
also contained larger disulfide-bonded complexes of >200 kDa 
(Figure 3, A and C, lane 7).
Reduction of the functional complexes containing BACE501 and 
TMX1C/A revealed a radiolabeled polypeptide with an apparent 
MW of 97 kDa in Figure 3, B and D, lane 7. This polypeptide was 
identified by WB and specific immunoprecipitation as the lectin 
chaperone CNX. The increased presence of CNX in the BACE and 
in the TMX1C/A immunoisolates from cells overexpressing BACE501 
(lane 7 in Figure 3, B and D, respectively) compared with cells that 
FIGURE 2: TMX1 preferentially associates with membrane-bound substrates. (A) Model 
polypeptides used in this study. (B) MEFs transfected with empty vectors (EV, lane 1), β1-tagged 
TMX1C/A (lane 2), or TMX1C/A in combination with HA-tagged BACE501, BACE501Δ, BACE457, 
or BACE457Δ (lanes 3–6, respectively). The HA-tagged model substrates were immunoisolated 
from cell lysates. Top, WB with an anti-HA antibody to reveal the model substrates; bottom, 
WB with a TMX1-specific antibody to reveal TMX1C/A. (C) Same as B, but TMX1C/A was 
immunoisolated from the same cell lysates with an anti-β1 antibody to verify the presence of the 
model proteins (top) in the immunocomplexes. (D) Same as B and C, for the soluble HA-tagged 
A1AT and the membrane-anchored A1AT-BACE (lanes 1 and 2, respectively). (E) Same as D, 
for the soluble HA-tagged A1AT and the membrane-anchored A1AT-CD3δ (lanes 1 and 2, 
respectively). G, mature Golgi form of BACE proteins; E, immature ER form; D, deglycosylated 
form; asterisk, antibody heavy chain recognized by the secondary antibody in WB.
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FIGURE 3: TMX1 selectively establishes mixed disulfides with membrane-bound BACE501. (A) MEFs were transfected 
with empty vector (EV), BACE501, BACE501Δ, HA-tagged TMX1, or TMX1C/A (lanes 1–5), BACE501 in combination with 
HA-tagged TMX1 or TMX1C/A (lanes 6 and 7), or BACE501Δ in combination with HA-tagged TMX1 or TMX1C/A (lanes 8 
and 9). The [35S]methionine/cysteine-radiolabeled model substrates were immunoisolated from cell lysates with 
anti-BACE antibodies. The immunocomplexes were separated under nonreducing conditions. (B) Same as A, but 
immunocomplexes were separated under reducing conditions. (C) Same as A, for complexes immunoisolated with 
anti-HA. (D) Same as C, analysis under reducing conditions. pOx501, partially oxidized BACE501; pOx501Δ, partially 
oxidized BACE501Δ; fOx501Δ, fully oxidized BACE501Δ; fOx501, fully oxidized BACE501; Red501, reduced BACE501; 
Red501Δ, reduced BACE501Δ; DBC, disulfide-bonded complexes; MD, mixed disulfides; CNX, calnexin.
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the oxidoreductase’s catalytic site is expected to delay substrate re-
lease from the ER. As for all glycoproteins, release of BACE501 from 
the ER can be monitored by the modification of protein-bound oli-
gosaccharides that occurs during transit in the Golgi compartment, 
which reduces the electrophoretic mobility of the polypeptide chain 
and confers resistance to EndoH cleavage (Rothman et al., 1984). To 
determine whether the coexpression of the TMX1 trapping mutant 
delays the attainment of the BACE501’s EndoH-resistant status, 
MEFs expressing only BACE501, BACE501 and TMX1, or BACE501 
and TMX1C/A were pulse labeled and chased for 10 (Figure 6A, 
lanes 1, 3, and 5) or 90 min (lanes 2, 4, and 6). After 10 min of chase, 
radiolabeled BACE501 expressed alone (Figure 6B, lanes 1 and 2) 
or coexpressed with TMX1 (lanes 5 and 6), or with TMX1C/A (lanes 9 
and 10) is sensitive to EndoH cleavage. This is consistent with the ER 
localization of the newly synthesized polypeptide (Solda et al., 
2007). The analysis after 90 min of chase showed that when ex-
pressed alone or with the wild- type form of TMX1, >85% of radio-
labeled BACE501 displayed EndoH-resistant oligosaccharides 
(Figure 6, B, lanes 3/4 and 7/8, respectively, and C). This is consis-
tent with the efficient export to the Golgi of this protein (Solda et al., 
2007). The stabilization of the TMX1:BACE501 mixed disulfides 
upon coexpression of TMX1C/A dramatically reduced the fraction of 
membrane. BACE501 (Figures 5A, lanes 1–6) or TMX1 (lanes 7–12) 
were revealed with HA- or TMX1-specific antibodies.
Confirming the data obtained with radiolabeled proteins (Figure 
3), the MD with the apparent MW of 90 kDa was only seen upon 
separation under nonreducing conditions of immunoisolates of cells 
cotransfected with BACE501 and TMX1C/A (Figure 5A, lane 5 for the 
BACE501 component of the MD and lane 11 for the TMX1 compo-
nent). The undetectable level of immunoreactivity in cells express-
ing the wild-type form of TMX1 (Figure 5A, lanes 3/4 and 9/10) con-
firms that TMX1C/A stabilizes the otherwise short-lived reaction 
intermediate. Disassembly upon sample reduction revealed 
BACE501 and TMX1 as the constituents of the mixed disulfides 
(Figure 5A, lanes 6 and 12, respectively). The absence of mixed di-
sulfides when the same experiment was performed with the soluble 
BACE501Δ variant further supported the selectivity of TMX1 for 
membrane-bound substrates (Figure 5B).
TMX1 and BACE501 maturation
Mixed disulfides are short-lived intermediates formed during the 
productive interaction between an oxidoreductase and its sub-
strates (Huppa and Ploegh, 1998; Molinari and Helenius, 1999). 
Their stabilization upon mutation of the resolving cysteine residue in 
FIGURE 4: Client-mediated association between TMX1 and CNX. (A) MEFs were cotransfected with an empty vector 
(EV, lanes 1 and 2), an empty vector and HA-tagged TMX1C/A (3 and 4), an empty vector and BACE501 (5 and 6), or 
BACE501 and HA-tagged TMX1C/A (7 and 8). Cells were incubated for 10 h in the absence (–) or presence (+) of CST 
(1 mM). The expression level of BACE501 was checked upon WB of the immunoisolated ectopic protein. (B) Same as A, 
but endogenous CNX with associated proteins was immunoisolated from cell lysates. Immunocomplexes were analyzed 
under reducing conditions. Ectopically expressed BACE501 and TMX1C/A were revealed with an anti-BACE and an 
anti-HA antibody, respectively. (C) Same as A, in cells treated with CST, cycloheximide (Chx), or tunicamycin (Tun) for 3 h. 
(D) Same as B for cells treated with CST, Chx, or Tun. G, mature Golgi form of BACE501; E, immature ER form; 
D, deglycosylated form.
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DISCUSSION
The mammalian ER contains 23 members of the PDI superfamily, 
marked by the presence of one or more thioredoxin-like domains 
(Ellgaard and Ruddock, 2005; Kozlov et al., 2010b; Galligan and 
Petersen, 2012; Tannous et al., 2015). Apart from this common fea-
ture, PDIs display different active-site compositions, enzymatic prop-
erties, domain arrangement, interacting partners, and subcompart-
mental and tissue distribution (Bulleid, 2012; Galligan and Petersen, 
2012). This high degree of divergence encourages the study of the 
individual PDI proteins because it suggests that they might have 
peculiar substrate specificity and/or participate in distinct oxidative, 
reductive, or isomerase pathways. Although informative, studies 
with purified enzymes fail to recapitulate the complex environment 
of the ER, where molecular crowding, participation in supramolecu-
lar complexes, and variable redox conditions in different compart-
mental microdomains may substantially affect the action of individ-
ual PDIs. Studies performed in living cells, where substrate specificity 
has been determined by using trapping mutants that substantially 
retard resolution of the mixed disulfide formed as intermediate 
during the folding or unfolding process, reveal a certain degree of 
EndoH-resistant BACE501 to <40% of the radiolabeled protein 
(Figure 6, B, lanes 11and 12, and C). In contrast, and consistent with 
the selectivity of TMX1 for membrane-bound polypeptides (Figures 
2–4), the secretion of BACE501Δ (Figure 6, D, right, and E) was unaf-
fected by coexpression of TMX1C/A.
It is of interest that only the coexpression of the TMX1 trapping 
mutant substantially reduced attainment of EndoH-resistant oli-
gosaccharide as a measure of delayed BACE501 secretion (Figures 
6 and 7, A, lanes 3 and 4, and B). ERdj5C/A did associate with 
BACE501 but only marginally delayed secretion (by 10–15%; 
Figure 7, A, lanes 5 and 6, and B). BACE501 coexpression with 
ERp57C/A (Figure 7, A, lanes 7 and 8, and B), ERp72C/A (Figure 7, 
A, lanes 9 and 10, and B), PDIC/A (Figure 7, A, lanes 11 and 12, 
and B) or P5C/A (Figure 7, A, lanes 13 and 14, and B; Ellgaard and 
Ruddock, 2005; Jessop et al., 2009; Rutkevich et al., 2010; Oka 
et al., 2013) had no consequences. Of note, and in contrast with 
TMX1 (Figure 6, D and E), ERdj5 also associated with BACE501Δ, 
thereby weakly reducing (by 20%) the secretion of this soluble 
model protein (Supplemental Figures S2, A, lanes 5/6 and 11/12, 
and B, and S3).
FIGURE 5: Characterization of TMX1C/A-BACE501 mixed disulfides by WB. (A) MEFs were cotransfected with BACE501 
and an empty vector (EV, lanes 1 and 2), TMX1 (3 and 4), or TMX1C/A (5 and 6). BACE501 was immunoisolated from cell 
lysates and immunocomplexes were analyzed under nonreducing (NR) or reducing (R) conditions. (B) Same as A, for 
BACE501Δ. red, reduced BACE; ox, oxidized BACE; DBC, disulfide-bonded complexes; MD, mixed disulfides.
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the catalytic site, the capacity to reduce insulin disulfides in vitro, 
and the role in translocation of catalytic toxin subunits across the ER 
membrane (Matsuo et al., 2001; Hatahet and Ruddock, 2009; 
Pasetto et al., 2012) support a role of TMX1 as an ER reductase and 
imply possible involvement of TMX1 in ERAD, where reduction of 
intermolecular and intramolecular disulfide bonds is a crucial step 
for misfolded protein retrotranslocation across the ER membrane 
(Hebert et al., 2010).
Of note, it was shown that access of folding polypeptides to the 
CNX chaperone system leads to assembly/stabilization of functional 
complexes between CNX and the oxidoreductase ERp57 (Frickel 
et al., 2002; Ellgaard and Frickel, 2003; Jessop et al., 2007) or be-
tween CNX and the peptidyl-prolyl isomerase CypB (Kozlov et al., 
2010a). Here we show that inhibition of endogenous or ectopic 
transmembrane protein association with CNX leads to disassembly/
destabilization of functional complexes between CNX and TMX1 
(Figure 4B, bottom, lane 3 vs. lane 4 for endogenous proteins and 
lane 7 vs. lane 8 for ectopic BACE501). On the other hand, seques-
tration of substrates in mixed disulfides with the trapping mutant 
version of TMX1 stabilizes the complexes between CNX and sub-
strates (Figure 4B, middle, lane 5 vs. lane 7). The fact that TMX1 is 
not glycosylated supports the conclusion that the membrane-bound 
redundancy (i.e., different PDIs may engage the same substrate in 
mixed disulfides; Bulleid, 2012). The high redundancy of the PDI 
system is also highlighted by the hardly detectable phenotypes in 
cell lines derived from knockout mice where surrogate PDIs can 
functionally replace PDIs that have been deleted (e.g., ERp72 effi-
ciently replaces ERp57 in assisting maturation of model glycopro-
teins (Solda et al., 2006), and other examples have been reported 
(Appenzeller-Herzog and Ellgaard, 2008; Kang et al., 2009; Zhang 
et al., 2009; Rutkevich et al., 2010).
The studies performed in living cells, however, also underscore 
the preference of PDIs for specific substrates or specific classes of 
substrates (e.g., ERp57 for glycoproteins entering the CNX/CRT 
cycle or ERp18 for proteins forming interchain disulfides; Oliver 
et al., 1997; Zapun et al., 1998; Molinari and Helenius, 1999; Frickel 
et al., 2002; Pollock et al., 2004; Solda et al., 2006; Jessop et al., 
2007, 2009). Our finding that the membrane-bound member of the 
PDI family, TMX1, shows selectivity for transmembrane polypep-
tides and virtually ignores the same cysteine- containing ectodo-
mains when not tethered at the ER membrane, regardless of their 
capacity to eventually attain the native structure, represents, to our 
knowledge, the first example of topology-determined substrate se-
lection of a PDI family member. The proline residue at position 2 of 
FIGURE 6: Coexpression of TMX1C/A selectively delays BACE501 maturation. (A) MEFs were cotransfected with 
BACE501 and an empty vector (EV, lanes 1 and 2), TMX1 (3 and 4), or TMX1C/A (5 and 6). Transfected cells were pulsed 
with [35S]methionine/cysteine for 13 min and chased for 10 or 90 min. Ectopically expressed BACE501 was 
immunoisolated from cell lysates with an anti-BACE antibody. (B) MEFs were cotransfected with BACE501 and an empty 
vector (lanes 1–4), TMX1 (5–8), or TMX1C/A (9–12). The maturation of immunoisolated radiolabeled BACE501 (i.e., the 
attainment of EndoH-resistant oligosaccharides upon arrival in the Golgi complex) was monitored after 10- and 90-min 
chases. (C) Quantification of the EndoH-resistant fraction of BACE501 after 90-min chase. Error bars show SDs of four 
independent experiments. (D) MEFs were cotransfected with BACE501Δ and an empty vector (EV, lanes 1 and 2), TMX1 
(3 and 4), or TMX1C/A (5 and 6). Left, disappearance of immunoisolated BACE501Δ from the cell lysates (Intracellular), 
which correlates with its secretion in the extracellular media (right, Secreted). (E) Quantification of secreted BACE501Δ 
after 90-min chase. The error bars show SD of three independent experiments. Significance analyzed by paired t test; 
n.s., not significant; **p < 0.01; ***p < 0.001. G, mature Golgi form of BACE501; E, immature ER form.
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to recognize membrane-bound and soluble BACE variants, 
respectively) were kind gifts of P. Paganetti (Neurocentro Svizzera 
italiana, Taverne, Switzerland). Genes encoding the HA-tagged 
TMX1 and TMX1C/A were subcloned in pCDNA3. The β1-tagged 
TMX1 and TMX1C/A variants were created by replacing the HA tag 
with an EFRH epitope, which is recognized by a monoclonal β1 
antibody (Paganetti et al., 2005). Plasmids encoding the mem-
brane-bound and soluble BACE are described in Molinari et al. 
(2002). V5-tagged ERdj5C/A-, ERp57C/A-, ERp72C/A-, PDIC/A-, and 
P5C/A-expressing vectors are described in Jessop et al. (2009) and 
Oka et al. (2013). Tunicamycin, cycloheximide, and CST (Sigma-
Aldrich) were used at final concentrations of 5 μg/ml, 50 μg/ml, 
and 1 mM, respectively.
Cell lines and transient transfection
MEFs were cultured in DMEM supplemented with 10% fetal bovine 
serum. Cells grown on 3.5/6 cm culture dishes were transfected 
with 3 μg/6 μg of total plasmid DNA, using the jetPrime reagent 
(Polyplus transfection). Experiments were performed 17 h after 
transfection.
Cell lysis and Western blots
Cells were washed with phosphate-buffered saline (PBS) containing 
20 mM N-ethylmaleimide (NEM) for 1 min and then lysed with 2% 
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS; Anatrace) in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES)–buffered saline, pH 6.8, supplemented with 20 mM 
NEM and protease inhibitors for 20 min on ice. Postnuclear super-
natants (PNSs) were collected by centrifugation at 10,000 × g for 
10 min. Samples were denatured and reduced in dithiothreitol 
(DTT)-containing sample buffer for 10 min at 65°C and separated by 
SDS–PAGE. Proteins were transferred to PVDF membranes with the 
Trans-Blot Turbo Transfer System (Bio-Rad, Cressier, Switzerland). 
Membranes were blocked with 10% (wt/vol) nonfat dry milk (Bio-
Rad) and stained with the aforementioned primary antibodies and 
horseradish peroxidase–conjugated secondary antibodies. Mem-
branes were developed using the Luminata Forte ECL detection 
system (Millipore, Schaffhausen, Switzerland), signals were detected 
with the ImageQuant LAS 4000 system in the standard acquisition 
mode (GE Healthcare Life Sciences, Glattbrugg, Switzerland), and 
bands were quantified using the Multi Gauge Analysis tool (Fujifilm). 
For each antigen, the linearity of the detected signal range was en-
sured with appropriate loading controls.
Metabolic labeling, immunoprecipitations, and EndoH 
treatment
Cells were pulse labeled with 0.1 mCi of [35S]-methionine/cysteine 
and chased in DMEM supplemented with 5 mM unlabeled methio-
nine and cysteine. Cells were lysed as described, and PNS and extra-
cellular medium were collected by centrifugation at 10,000 × g for 
10 min and precleared with protein A beads (Sigma-Aldrich; 
1:10 [wt/vol] swollen in PBS) for 1 h at 4°C. Immunoprecipitation was 
performed with protein A beads and specific antibody overnight at 
4°C. After extensive washing of the immunoprecipitates with 0.5% 
CHAPS, beads were resuspended in sample buffer without (nonre-
ducing conditions) or with DTT (reducing conditions) and denatured 
for 10 min at 65°C. Samples were subjected to SDS–PAGE. After 
exposure of the gels to autoradiography films (GE Healthcare, Fuji), 
films were scanned with the Typhoon FLA 9500 software, version 1.0. 
Bands were quantified using ImageQuant software (Molecular 
Dynamics, GE Healthcare). For EndoH (New England Biolabs, 
Allschwil, Switzerland) treatment, immunoisolated proteins were 
oxidoreductase TMX1 participates in functional complexes with the 
membrane-bound lectin CNX. Having PDI members with different 
topologies possibly determining their substrate selection is reminis-
cent of the lectin chaperone system, in which the membrane-bound 
CNX and the soluble CRT show different substrate specificity to 
broaden the range of newly synthesized gene products that can be 
assisted early after synthesis in the ER (Wada et al., 1995; Hebert 
et al., 1997; Danilczyk et al., 2000; Molinari et al., 2004). Of note, 
topology-determined preferences have also been reported for the 
supramolecular complexes that regulate delivery at and dislocation 
across the ER membrane of misfolded polypeptides to be degraded 
into the cytosol, where soluble misfolded polypeptides show strict 
requirement for members of the HRD1 complex (Bernasconi et al., 
2010; Ninagawa et al., 2011). Thus accumulating evidence shows 
that substrate topology is a key factor in determining engagement of 
folding, quality control, and degradation pathways to ensure produc-
tion of the cellular proteome in appropriate quantity and quality.
MATERIALS AND METHODS
Antibodies, expression plasmids, and inhibitors
Antibodies to TMX1 and HA were from Sigma-Aldrich (Buchs, 
Switzerland) and antibody to V5 from Invitrogen (Lucerne, 
Switzerland). The rabbit polyclonal antisera 855 and 809 (used 
FIGURE 7: Trapping mutants of several PDI members and BACE501 
maturation. (A) MEFs were cotransfected with BACE501 in 
combination with an empty vector (EV, lanes 1 and 2), TMX1C/A (3 and 
4), ERdj5C/A (5 and 6), ERp57C/A (7 and 8), ERp72C/A (9 and 10), PDIC/A 
(11 and 12), or P5C/A (13 and 14). Ectopically expressed BACE501 was 
immunoisolated from cell lysates with an anti-BACE antibody. The 
maturation of radiolabeled BACE501 was monitored as in Figure 6B. 
(B) Quantification of the EndoH-resistant fraction of BACE501 after 
90-min chase. Error bars show SDs of three independent experiments. 
Significance analyzed by paired t test; n.s., not significant; *p < 0.05; 
**p < 0.01. G, mature Golgi form of BACE501; E, immature ER form.
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split into two aliquots and incubated in the presence or absence of 
5 mU of EndoH for 2h at 37°C. Samples were then analyzed by re-
ducing SDS–PAGE.
Mass spectrometry
Confluent MEFs transfected with an empty vector or transfected 
with HA-tagged TMX1C/A were rinsed with PBS and 20 mM NEM. 
Cells were lysed with 2% CHAPS (Anatrace) in HEPES-buffered 
saline, pH 6.8, supplemented with 20 mM NEM and protease in-
hibitors for 20 min on ice. Immunoisolates were washed three 
times with lysis buffer. Mass spectrometry analysis was performed 
at the Protein Analysis Facility, University of Lausanne, Lausanne, 
Switzerland.
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Supplementary figure 1. A, EndoH assay. MEF were co-transfected with BACE501 and an 
empty vector (EV, lanes 1-2), TMX1 (lanes 3-4) or TMX1C/A (lanes 5-6). Transfected cells were 
pulsed with 
35
S-methionine and -cysteine for 13 min and chased for 10 min. At this time of 
chase, the newly synthesized BACE501 variants are still folding in the ER as confirmed by the 
EndoH-sensitivity of their oligosaccharides. B, BACE501 electrophoretic mobility. MEF were 
transfected with BACE501. 35S-methionine and -cysteine radiolabeled model substrate was 
immunoisolated from cell lysates with anti-BACE antibodies. The immunocomplexes were 
separated under non-reducing (lane 1) and reducing (lane 2) conditions. pOx, partially oxidized 
BACE; fOx, fully oxidized BACE; Red, reduced BACE. 
 
 
 
  
Supplementary figure 2. Trapping mutants of several PDI members and BACE501Δ 
secretion. A, MEF were co-transfected with BACE501Δ in combination with an empty vector 
(EV, lanes 1-2), TMX1C/A (lanes 3-4), ERdj5C/A (lanes 5-6), ERp57C/A (lanes 7-8), ERp72C/A 
(lanes 9-10), PDIC/A (lanes 11-12) or P5C/A (lanes 13-14). Ectopically expressed BACE501Δ was 
immunoisolated from cell lysates with an anti-BACE antibody. The upper panel shows the 
disappearance of BACE501Δ from the cell lysates (intracellular) that correlates with its secretion 
in the extracellular media (lower panel, Secreted). B, Quantification of secreted BACE501Δ after 
90 min chase. The error bars show standard deviations of two independent experiments.  
 
  
 
Supplementary figure 3. Expression levels of the PDI trapping mutants. MEF were co-
transfected with BACE501 in combination with the V5-tagged ERdj5
C/A 
(1-2), ERp57
C/A 
(3-4), 
ERp72
C/A 
(5-6), PDI
C/A
 (7-8) or P5
C/A 
(9-10). Ectopically expressed PDIs trapping mutants were 
immunoisolated from cell lysates with an anti-V5 antibody.  
 
 
